Abstract
This chapter deals with the most culturally accepted legal drugs. As might be expected, these relatively mild (per usual dose) and highly attractive psychoactive substances have the widest use in our society. Despite the relatively benign effects that can be expected at low doses, the high prevalence of use results in frequent morbidity and (for tobacco) even a high level of mortality. These substances are discussed here because of the interaction between their use and various psychiatric disorders, as well as because of medical complaints that can be seen in emergency settings. The chapter first deals with the xanthines, including caffeine, and then goes on to a discussion of nicotine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Rall, T. W. Central nervous system stimulants: The methylxanthines. In A. G. Gilman, L. S. Goodman, T W. Rall, und F. Murad (Eds.), The Pharmacological Basis of Therapeutics ( 7th ed. ). New York: Macmillan, 1985, pp. 589–603.
Lutz, E. G. Restless legs, anxiety and caffeinism. Journal of Clinical Psychiatry 39: 693–698, 1978.
Victor, B. S., Lubetsky, M., und Greden, J. F. Somatic manifestation of caffeinism. Journal of Clinical Psychiatry 42: 185–188, 1981.
Krnjevic, K. Metabolism of theophylline to caffeine in human fetal liver. Science 206:1319–1322, 1979.
Kalsner, S. A coronary vasoconstrictor substance is present in regular and “decaffeinated” forms of both percolated and instant coffee. Life Sciences 20:1689–1696, 1977.
Nagy, M. Caffeine content of beverages and chocolate. Journal of the American Medical Association 229: 337–339, 1974.
Diamo, V. J. M., und Garriott, J. C. Lethal caffeine poisoning in a child. Forensic Science 3:275-278, 1974.
Mikkelsen, E. J. Caffeine and schizophrenia. Journal of Clinical Psychiatry 83: 732–735, 1978.
Mitchelle, M. C., Hoyumpa, A. M., Schenker, S., Inhibition of caffeine elimination by short-term ethanol administration. Journal of Laboratory and Clinical Medicine 101: 826–834, 1983.
Uhde, T. W., Boulenger, J. P., Jimerson, D. C., und Post, R. M. Caffeine: Relationship to human anxiety, plasma MHPG, and cortisol. Psychopharmacology Bulletin 20: 426–430, 1984.
Fernstrom, M. H., Bazil, C. W., und Fernstrom, J. D. Caffeine injection raises brain tryptophan level, but does not stimulate the rate of serotonin synthesis in rat brain. Life Sciences 35: 1241 1247, 1984.
Procter, A. W., und Greden, J. F. Caffeine and benzodiazepine use. American Journal of Psychiatry 139: 32, 1981.
Gould, R. J., Murphy, K. M. M., Katims, J. J., und Snyder, S. H. Caffeine actions and adenosine. Paper presented at the American College of Neuropsychopharmacology Annual Meeting, San Juan, Puerto Rico, December 12–16, 1983.
Boulenger, J. P., Uhde, T. W., Wolff, E. A., und Post, R. V. Increased sensitivity to caffeine in patients with panic disorders. Archives of General Psychiatry 41:1067–1071, 1984.
Chamey, D. S., Heninger, G. R., und Jatlow, P. I. Increased anxiogenic effects of caffeine in panic disorders. Archives of General Psychiatry 42: 233–243, 1985.
Marangos, P. J., und Boulenger, J. P. Anxiety, caffeine and the adenosine receptor. Paper presented at the American College of Neuropsychopharmacology Annual Meeting, San Juan, Puerto Rico, December 1984.
Judd, L. Effects of psychotropic drugs on cognition and memory. In H. Y. Meltzer (Ed.), Psycho-pharmacology: The Third Generation of Progress. New York: Raven Press, 1987, pp. 1467–1476.
Neil, J. F., Himmelhock, J. M., Mallinger, A. G., Caffeinism complicating hypersomnic depressive episodes. Comparative Psychiatry 19: 337–385, 1978.
Becker, A. B., Simons, K. J., Gillespie, C. A., und Simons, F. E. R. The bronchodilator effects and pharmacokinetics of caffeine in asthma New England Journal of Medicine 310: 743–746, 1984.
Cohen, S. Pathogenesis of coffee-induce gastrointestinal symptoms. New England Journal of Medicine 303:122–124, 1980.
Kulkanek, F., Linde, O. K., und Meisenbe g, G. Prescription of antipsychotic drugs in interaction with coffee or tea. Lancet 2: 1130, 1979.
Boublik, J. H., Quinn, M. J., und Clement J. A. Cofee contains poten opiate receptor binding activity. Nature (London) 301:246–248
Elins, R. N., Rapoport, J. L., Zahn, T. P et al. Acute effects of caffeine in normal prepubertal boys. American Journal of Psychiatry 183:178–182,1981.
Gilliland, K., und Andress, D. Ad lib caffeine consumption symptoms of caffeinism, and academic performance. American Journal of Psychiatry 138: 512–514, 1981.
Tennant, F. S., und Detels, R. Relationship alcohol, cigarette and drug abuse in adulthood with alcohol cigarette and coffee consumption inchildhood. Preventive Medicine 5: 70–77, 1976.
Rapoport, J. L., Berg, C. J., Ismond, D. R., et al. Behavioral effects of caffeine in children. Archives of General Psychiatry 41:1073–1079, 1984.
Greden, J. F., Fontaine, P., Lubetsky, feinism among psychiatric inpatients. Am M., et al. Anxiety and depression associated with caffeinism among paychiatric inpatients. American Jourican of Psychiatry 135: 963–966, 1978.
Abe, K. Reactions to coffee and alcohol in monozygotic twins. Journal of Psychosomatic Research 12:199–203, 1968.
Schuckit, M. A. Anxiety treatment: A commonsense approach. Postgraduate Medicine 75: 52–63, 1984.
Breier, A., Charney, D. S., und Heinger, G. R. Agoraphobia with panic attcks. Archives of General Psychiatry 43: 1029–1036, 1986.
Lee, M. A., Fiegel, P., Greden, J. F., und Cameron, O. G. Caffeine as an anxiogenic agent: Comparison of panic and depressed patient.. Paper presented at the 41st Meeting of the Society of Biological Psychiatry, Washington, D.C., May 7–11, 1986.
Dimaio, V., und Garriott, J. Lethal caffein poisoning. Forensic Science 3: 275–278, 1974.
Sours, J. A. Case reports of anorexia ne osa and caffeinism. American Journal of Psychiatry 140: 235–236, 1983.
Mathew, R. J., Barr, D. L., und Weinman,. L. Caffeine and cerebral blood flow. British Journal of Psychiatry 143:604–608, 1983.
Gibson, C. J. Caffeine withdrawal elevat s urinary MHPG excretion. New England Journal of Medicine 304: 363, 1981.
White, B. C., Lincoln, C. A., Pearce, N. W., Anxiety and muscle tension as consequences of caffeine withdrawal. Science 209: 1547
Kozlowsky, L. T. Effect of caffeine on coff drinking Nature (London) 264: 354–355, 1976
Bauer, A. R., Rank, R. K., und Kerr, R. The effects of prolonged coffee intake on genetically identical mice. Life Sciences 21: 63–70, 1
LaCroix, A. Z., Mead, L. A., Liang, K. Y., Coffee consumption and the incidence of coronary heart disease. New England Journal of Medicine 315:977-982, 1986.
Roth, T., Zorick, F., Roehrs, T., Insomnia treatment: A new pharmacological approach.Paper presented at the American Psychiatric Association Annual Meeting, Toronto, Ontario, Canada, May 1982
Heuch, I., Kvale, G., Jacobsen, B. K., und Bjelke, E. Use of alcohol, tobacco, and coffee, and risk of pancreatic cancer. British Journal of C ncer 48: 637–643, 1983.
Binstock, M., Krakow, D., Stamler, J, et al. Coffee and pancreatic cancer: An analysis of international mortality data. American Journal of Epidemiology 118: 630–640, 1983.
Vaughn, R. Coffee in pregnancy. Lancet 1: 554, 1981.
Hoff, W. V. Caffeine in pregnancy. Lancet 1: 1020, 1982.
Jaffe, J. H. Drug addiction and drug abuse. In A. G. Gilman, L. S. Goodman, T. W. Rall, und F. Murad (Eds.), The Pharmacological Basis of Therapeutics ( 7th ed. ). New York: Macmillan, 1985, pp. 554–558.
Janiger, O., und deRios, M. D. Suggestive hallucinogenic properties of tobacco. Medical Anthropology Newsletter 4: 1–6, Aug. 1973.
Krasnegor, N. A. Introduction. In N. A. Krasnegor (Ed.), Cigarette Smoking as a Dependence Process: Research Monograph 23. Rockville, Maryland: National Institute on Drug Abuse, 1979, pp. 1–3.
Pechacek, T. F. An overview of smoking behavior and its modification. In N. A. Krasnegor (Ed.), Behavioral Analyses and Treatment of Substance Abuse: Research Monograph 25. Rockville, Maryland: National Institute on Drug Abuse, 1979, pp. 92–113.
Dilsaver, S. C., Majchrzak, M. J., und Alessi, N. E. Chronic treatment with amitriptyline produces supersensitivity to nicotine. Biological Psychiatry 23:169–175, 1988.
Meade, T. W., Imeson, J., und Stirling, Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 2: 986–988, 1987.
Kozlowsky, L. T., Jarvik, M. E., und Gritz, E. R. Nicotine regulation and cigarette smoking. Clinical Pharmacology and Therapeutics 17: 93–97, 1975.
Schachter, S., Silverstein, B., Kozlowsky, L. T., Studies of the interaction of psychological and pharmacological determinants of smoking. Journal of Experimental Psychology: General 106: 3–40, 1977.
Taylor, P. Ganglionic stimulating and blocking agents. In A. G. Gilman, L. S. Goodman, T. W. Rall, und F. Murad (Eds.), The Pharmacological Basis of Therapeutics ( 7th ed. ). New York: Macmillan, 1985, pp. 215–221.
Tonnesen, P., Fryd, V., Hansen, M., Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking. New England Journal of Medicine 318: 15–18, 1988.
Connolly, G. N., Winn, D. M., Hecht, S. S., et al. The reemergence of smokeless tobacco. New England Journal of Medicine 314: 1020–1027, 1986.
Jarvik, M. E. Nicotine as a psychoactive drug-Panel summary. Psychopharmacology Bulletin 22: 882–883, 1986.
Rose, J. E. Cigarette smoking blocks caffeine-induced arousal. Alcohol and Drug Research 7: 4955, 1986.
Pomerleau, O. F. Nicotine as a psychoactive drug: Anxiety and pain reduction. Psychopharmacology Bulletin 22: 865–869, 1986.
Domino, E. F. Nicotine as a unique psychoactive drug: Arousal with skeletal muscle relaxation. Psychopharmacology Bulletin 22: 870–873, 1986.
Rosecrans, J. A. Nicotine as a discriminative stimulus. In N. A. Krasnegor (Ed.), Cigarette Smoking as a Dependence Process: Research Monograph 23. Rockville, Maryland: National Institute on Drug Abuse, 1979, pp. 58–69.
Grunberg, N. E. Nicotine as a psychoactive drug: Appetite regulation. Psychopharmacology Bulletin 22: 875–881, 1986.
Mintz, J. Alcohol increases cigarette smoking. Addictive Behaviors 10: 203–207, 1985.
Abood, L. G., Lowy, K., und Booth, H. Acute and chronic effects of nicotine. In N. A. Krasnegor (Ed.), Cigarette Smoking as a Dependence Process: Research Monograph 23. Rockville, Maryland: National Institute on Drug Abuse, 1979, pp. 136–149.
Hughes, J. R., Gust, S. W., und Pechacek, T. F. Prevalence of tobacco dependence and withdrawal. American Journal of Psychiatry 144: 205–208, 1987.
Davis, R. Current trends in cigarette smoking and marketing. New England Journal of Medicine 316: 725–732, 1987.
Fielding, J. E. Smoking: Health effects and control. New England Journal of Medicine 313:491-498, 1985.
Warner, K. E. Cigarette smoking in the 1970’s. The impact of the anti-smoking campaign on consumption. Science 211:729–731, 1981.
Chapman, S. Stop-smoking clinics: A case for their abandonment. Lancet 1: 918–920, 1985.
Smart, R. G., Goodstadt, M. S., Adlaf, E. M., Trends in the prevalence of alcohol and other drug use among Ontario students: 1977–1983. Canadian Journal of Public Health 76:157–161, 1985.
Hughes, J. R., Hatsukami, D. K., Mitchell, J. E., und Dahlgren, L. A. Prevalence of smoking among psychiatric outpatients. American Journal of Psychiatry 143: 993–997, 1986.
Hughes, J. R.: Genetics of smoking: A brief review. Behavioral Therapy 17: 335–345, 1986.
Crumpacker, D. W., Cederlof, R., Friberg. L., et al. A twin methodology for the study of genetic and environmental control of variation in human smoking behavior. Acta Geneticae Medicae et Gemellologiae 28: 173–195, 1979.
Henningfield, J. E. Pharmacologic basis and treatment of cigarette smoking. Journal of Clinical Psychiatry 45: 24–34, 1984.
O’Donnell, J. A. Cigarette smoking as a precursor of illicit drug use. In N. A. Krasnegor (Ed.), Cigarette Smoking as a Dependence Process: Research Monograph 23. Rockville, Maryland: National Institute on Drug Abuse, 1979, pp. 30–43.
Kozlowsky, L. T., Herman, C. P., und Frecker, R. C. What researchers make of what cigarette smokers say: Filtering smokers’ hot air. Lancet 1: 699–700, 1980.
Hughes, J. R., und Hatsukami, D. Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry 43: 289–294, 1986.
Hughes, J. R., Hatsukami, D. K., und Skoog, K. P. Physical dependence on nicotine in gum. Journal of the American Medical Association 255: 3277–3279, 1986.
Hughes, J. R., Arana, G., Amori, G., et al. Effect of tobacco withdrawal on the dexamethasone suppression test. Biological Psychiatry 23: 96–98, 1988.
Lichtenstein, E. Social learning, smoking and substance abuse. In N. A. Krasnegor (Ed.), Behavioral Analysis and Treatment of Substance Abuse: Research Monograph 25. Rockville, Maryland: National Institute on Drug Abuse, 1979, pp. 114–127.
Quellet, B. L., Romeder, J. M., und Lance, J. M. Premature mortality attributable to smoking and hazardous drinking in Canada. American Journal of Epidemiology 109:451–463, 1979.
Willett, W. C., Green, A., Stampfer, M. J., Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. New England Journal of Medicine 317:1303-1309, 1987.
Kaufman, D. W., Palmer, J. R., Rosenberg, L., und Shapiro, S. Cigar and pipe smoking and myocardial infarction in young men. British Medical Journal 294:1315–1316, 1987.
Blot, W. J., McLaughlin, J. K., Winn, D. M. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Research 48: 3282–3287, 1988.
Michnovicz, J. J., Hershcopf, R. J., Naganuma, H., Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. New England Journal of Medicine 315: 1305–1309, 1986.
Kaufman, D. W., Helmrich, S. P., Rosenberg, L., Nicotine and carbon monoxide content of cigarette smoke and the risk of myocardial infarction in young men. New England Journal of Medicine 308: 409–413, 1983.
Rosenberg, L., Kaufman, D. W., Helmrich, S. P., und Shapiro, S. The risk of myocardial infarction after quitting smoking in men under 55 years of age. New England Journal of Medicine 313:1511-514, 1985.
Caro, C. G., Parker, K. H., Lever, M. J. und Fish, P. J. Effect of cigarette smoking on the pattem of arterial blood flow: Possible insight into mechanisms underlying the development of arteriosclerosis. Lancet 2:11–14,1987
Abbott, R. D., Yin, Y., Reed, D. M., und Yano, K. Risk of stroke in male cigarette smokers. New England Journal of Medicine 315: 717–720, 1986.
Cook, D. G., Pocock, S. J., Shaper, A. G., und Kussick, S. J. Giving up smoking and the risk of heart attacks. Lancet 2:1376–1378, 1986.
Everson, R. B. Individuals transplacentally exposed to maternal smoking may be at increased cancer risk in adult life. Lancet 2:123–126, 1980.
Christiansen, R. Gross deficiencies observed in the placentas of smokers and nonsmokers. American Journal of Epidemiology 110: 178–187, 1979.
Greenberg, R. A., Haley, N. J., Etzel, R. A., und Loda, F. A. Measuring the exposure of infants to tobacco smoke. New England Journal of Medicine 310:1075–1078, 1984.
Fabia, J., und Drolette, M. Twin pairs, smoking in pregnancy and perinatal mortality. American Journal of Epidemiology 112: 404–408, 1980.
Evans, H. J., Fletcher, J., Torrence, M., Sperm abnormalities and cigarette smoking. Lancet 1:627–629, 1981.
White, J. R., und Froeb, H. F. Small-airways of dysfunction in nonsmokers chronically exposed to tobacco smoke. New England Journal of Medicine 302: 720–723, 1980.
Sontag, S., Graham, D Y, Belsito, A., et al. Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. New England Journal of Medicine 311: 689–693, 1984.
Boyko, E. J. Risk of ulcerative colitis among cigarette smokers. New England Journal of Medicine 316: 707–710, 1987.
Jensen, J., Christiansen, C., und Rodbro, P. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. New England Journal of Medicine 313: 873–875, 1985.
Lam, W., Sacks, H. S., Sze, P. C. und Chalmers, T. C. Meta-analysis of randomized controlled trials of nicotine chewing-gum. Lancer 2: 27–30, 1987.
Atkinson, A. B., und Townsend, J. L. Economic aspects of reduced smoking. Lancet 2: 494–492, 1977.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Schuckit, M.A. (1989). Xanthines (Caffeine) and Nicotine. In: Drug and Alcohol Abuse. Critical Issues in Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0767-0_12
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0767-0_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-0769-4
Online ISBN: 978-1-4757-0767-0
eBook Packages: Springer Book Archive